Crohn’s Disease-Associated Lower Gastrointestinal Cancer
Atlas of Inflammatory Bowel Disease-Associated Intestinal Cancer: Examining the Macroscopic Images of Small and Large Intestine, Page: 11-17
2022
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Book Chapter Description
Crohn’s disease (CD) carries the same risk of carcinogenesis as ulcerative colitis (UC) [1], and the number of CD-associated cancer cases is increasing in Japan concurrent with an increase in the number of long-term cases [2]. However, the number of CD cases complicated with cancer is much lower than that of UC cases complicated with cancer. Additionally, the morphological analysis of CD-associated gastrointestinal cancers is not as advanced because the entire gastrointestinal tract is at risk; endoscopy is limited by stenosis, fistulae, and anal lesions; and frequency of CD-associated cancers is high in the rectal and anal regions, where gastroenterologists are least familiar. In this chapter, we present our experience with CD-associated lower gastrointestinal cancers and describe current issues, focusing on diagnosis [3]. The description of the presented cases is included in Sect. 3 of the text, and the corresponding cases are indicated by (). The description of cancer lesions is based on the 9th edition of the Japanese Classification of Colorectal, Appendiceal, and Anal Carcinoma [4].
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85168898438&origin=inward; http://dx.doi.org/10.1007/978-981-19-3413-1_3; https://link.springer.com/10.1007/978-981-19-3413-1_3; https://dx.doi.org/10.1007/978-981-19-3413-1_3; https://link.springer.com/chapter/10.1007/978-981-19-3413-1_3
Springer Science and Business Media LLC
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know